
VaMPIRE consortium meets in Rome to keep track of the scientific and clinical advances of the project
The consortium of the VaMPiRE project (Validation of α-synuclein Modifications in Parkinson’s disorder Evolution) met in Rome to review the

The consortium of the VaMPiRE project (Validation of α-synuclein Modifications in Parkinson’s disorder Evolution) met in Rome to review the

A delegation of around 20 organisations from Türkiye is visiting Catalonia this week to explore the region’s health and life

Leitat took part in four sessions and presented a sensorised robotics demonstration at BNEW 2026, bringing different technological capabilities related

From 29 September to 1 October, Leitat took part in Biospain 2026 in Bilbao, bringing together its expertise in biotechnology,

Leitat will participate in Cosmetorium 2026, taking place on 21 and 22 October at La Farga in L’Hospitalet de Llobregat,

Leitat supports the pharmaceutical, biotechnology and MedTech industries throughout the development of chemical, biological and natural compounds in preclinical research,

Leitat will participate in MicroTAS 2026, the international conference on miniaturized systems for chemistry and life sciences, taking place from

On 8-9th September, the partners of the APPEAL project gathered once again for their annual consortium meeting, hosted by PharmAI

Leitat will participate in Biospain 2026, one of Europe’s leading events for the biotechnology industry, taking place from 29 September

Ultrasensitive immunoassay for the early detection of non-small cell lung cancer through biomarkers in tumour-derived extracellular vesicles. Abstact: ONCOSOMIX is

Development of a complex secretome-based biological product for the regeneration of acute muscle injuries Abstract: The HERACLES project aims to

Development of new prevention and diagnostic tools for antibiotic-resistant Klebsiella pneumoniae infections Abstract: The project aims to advance the clinical development

Leitat, Ona Therapeutics and IRB Barcelona Collaborate to Develop a New Therapy for Colorectal Cancer The objective of the ADC-CRC

Recently, the PREDICTFTD consortium gathered in Desenzano del Garda (Italy) for a two-day meeting hosted by the University of Verona.

Tthe VaMPIRE consortium gathered in Barcelona for a two-day meeting hosted by the project coordinator, Linkcare Health Services, on 23-24th

Oncomatryx, partner and coordinator of the NEXTOM project, visited Leitat’s facilities at the Parc Científic de Barcelona (PCB) for an
Utilitzem cookies per millorar la teva experiència de navegació, publicar anuncis o contingut personalitzats i analitzar el nostre trànsit. En fer clic a "Acceptar-ho tot", acceptes l'ús que fem de les cookies.